A Case of Crystal-Associated Colitis Caused by Sevelamer
Annals of Internal Medicine: Clinical CasesSevelamer, a calcium-free phosphate binder used in chronic kidney disease, can lead to gastrointestinal side effects and, rarely, crystal-associated colitis. We present a case of sevelamer-induced colitis in a 66-year-old man with end-stage renal disease.
Ryan Plunkett +5 more
doaj +1 more source
Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE−/−) mice with chronic renal failure [PDF]
, 2017 Background. In chronic kidney disease (CKD) patients, the intake of calcium-based phosphate binders is associated with a marked progression of coronary artery and aortic calcification, in contrast to patients receiving calcium-free phosphate binders. The
Chasseraud, Maud +10 more
core
Uso del sevelamer en la enfermedad renal crónica. Más allá del control del fósforo
Nefrología, 2015 El sevelamer es un captor no cálcico de fósforo que se utiliza en la ERC avanzada y en diálisis para el control de la hiperfosforemia. Varios estudios experimentales, observacionales y ensayos clínicos han mostrado que el sevelamer tiene efectos ...
Laura Rodríguez-Osorio +6 more
doaj +1 more source
The connections between vascular calcification and bone health [PDF]
, 2013 Vascular calcification, bone loss and increased fracture risk are age-associated disorders. Several epidemiological studies have suggested a relationship between vascular calcification, impaired bone metabolism and increased mortality.
Cannata, J.B. (Jorge) +2 more
core
Effect of the Phosphate Binder Sevelamer Carbonate on the Bioavailability of Enarodustat, an Oral Erythropoiesis Stimulating Agent [PDF]
, 2023 Sudhakar M. Pai, Hiroyuki Yamada
openalex +1 more source
Linchuang shenzangbing zazhi, 2018 Objective The objective of this review is to inquire the efficiency and safety of sevelamer to decrease the level of serum phosphate of the patients with maintenance hemodialysis.Methods According to the strict inclusion and exclusion criteria we search ...
YANG Ling
doaj
Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease [PDF]
, 2016 Brett McGettigan +7 more
openalex +1 more source
PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.
PLoS ONE, 2017 The effects of PA21, a novel iron-based and non-calcium-based phosphate binder, on hyperphosphatemia and its accompanying bone abnormality in chronic kidney disease-mineral and bone disorder (CKD-MBD) were evaluated.
Atsushi Yaguchi +3 more
doaj +1 more source
PILOTSTUDY TO EVALUATE THE EFFECT OF PHOSPHORUSBINDERS ON FGF23
Kidney Research and Clinical Practice, 2012 The Netherlands Fibroblast growth Factor 23 (FGF23) is independently associated with cardiovasculair outcome. A reduction of dietary phosphorus intake in healthy individuals leads to a decrease of FGF23.
A.Bouma de Krijger +3 more
doaj +1 more source
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword [PDF]
, 2017 The Kidney Disease: Improving Global Outcomes (KDIGO) 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD) represents a selective update of the ...
Wheeler, DC, Winkelmayer, WC
core